Metlife Inc (MET) concluded trading on Thursday at a closing price of $77.59, with 4.0 million shares of worth about $310.65 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -1.23% during that period and on May 08, 2025 the price saw a gain of about 1.11%. Currently the company’s common shares owned by public are about 673.29M shares, out of which, 561.49M shares are available for trading.
Stock saw a price change of 2.40% in past 5 days and over the past one month there was a price change of 13.40%. Year-to-date (YTD), MET shares are showing a performance of -5.24% which increased to 8.99% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $65.21 but also hit the highest price of $89.05 during that period. The average intraday trading volume for Metlife Inc shares is 3.76 million. The stock is currently trading 4.10% above its 20-day simple moving average (SMA20), while that difference is down -0.49% for SMA50 and it goes to -3.14% lower than SMA200.
Metlife Inc (NYSE: MET) currently have 673.29M outstanding shares and institutions hold larger chunk of about 77.03% of that.
The stock has a current market capitalization of $52.09B and its 3Y-monthly beta is at 0.84. PE ratio of stock for trailing 12 months is 12.63, while it has posted earnings per share of $6.14 in the same period. Its PEG reads 1.07 while making debt-to-equity ratio of 0.72. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MET, volatility over the week remained 2.12% while standing at 3.30% over the month.
Stock’s fiscal year EPS is expected to rise by 12.76% while it is estimated to increase by 12.71% in next year. EPS is likely to grow at an annualized rate of 11.82% for next 5-years, compared to annual growth of -0.38% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by BMO Capital Markets on January 23, 2025 offering a Market perform rating for the stock and assigned a target price of $97 to it. Coverage by TD Cowen stated Metlife Inc (MET) stock as a Buy in their note to investors on October 09, 2024, suggesting a price target of $97 for the stock. On September 05, 2024, Barclays Initiated their recommendations, while on January 08, 2024, Goldman Upgrade their ratings for the stock with a price target of $80. Stock get an Overweight rating from Barclays on November 17, 2023.
